Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
Published 2014 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Discovering novel anti-HCV compounds with inhibitory activities toward HCV NS3/4A protease
Authors
Keywords
-
Journal
ACTA PHARMACOLOGICA SINICA
Volume 35, Issue 8, Pages 1074-1081
Publisher
Springer Nature
Online
2014-07-28
DOI
10.1038/aps.2014.55
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Isothiafludine, a novel non-nucleoside compound, inhibits hepatitis B virus replication through blocking pregenomic RNA encapsidation
- (2014) Li Yang et al. ACTA PHARMACOLOGICA SINICA
- Synthesis and Hepatitis C Antiviral Activity of 1-Aminobenzyl-1H-indazole-3-carboxamide Analogues
- (2013) Jing-Jing Shi et al. ChemMedChem
- Future therapies for chronic hepatitis C
- (2013) Noura M. Dabbouseh et al. Nature Reviews Gastroenterology & Hepatology
- Sofosbuvir for Previously Untreated Chronic Hepatitis C Infection
- (2013) NEW ENGLAND JOURNAL OF MEDICINE
- Discovery and Optimization of 2,4-Diaminoquinazoline Derivatives as a New Class of Potent Dengue Virus Inhibitors
- (2012) Bo Chao et al. JOURNAL OF MEDICINAL CHEMISTRY
- Mycophenolate mofetil inhibits hepatitis C virus replication in human hepatic cells
- (2012) Li Ye et al. VIRUS RESEARCH
- Boceprevir for Untreated Chronic HCV Genotype 1 Infection
- (2011) Fred Poordad et al. NEW ENGLAND JOURNAL OF MEDICINE
- Response-Guided Telaprevir Combination Treatment for Hepatitis C Virus Infection
- (2011) Kenneth E. Sherman et al. NEW ENGLAND JOURNAL OF MEDICINE
- Boceprevir for Previously Treated Chronic HCV Genotype 1 Infection
- (2011) Bruce R. Bacon et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Retreatment of HCV Infection
- (2011) Stefan Zeuzem et al. NEW ENGLAND JOURNAL OF MEDICINE
- Telaprevir for Previously Untreated Chronic Hepatitis C Virus Infection
- (2011) Ira M. Jacobson et al. NEW ENGLAND JOURNAL OF MEDICINE
- WSS45, a sulfated α-D-glucan, strongly interferes with Dengue 2 virus infection in vitro
- (2010) Xian-kun Tong et al. ACTA PHARMACOLOGICA SINICA
- Chemical genetics strategy identifies an HCV NS5A inhibitor with a potent clinical effect
- (2010) Min Gao et al. NATURE
- The global burden of hepatitis C
- (2009) Daniel Lavanchy LIVER INTERNATIONAL
- Compensatory mutations in NS3 and NS5A proteins enhance the virus production capability of hepatitis C reporter virus
- (2009) Qingxia Han et al. VIRUS RESEARCH
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationAdd your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload Now